Dab2 is pivotal for endothelial cell migration by mediating VEGF expression in cancer cells (Q39408655)

11 September 2017

Dab2 is pivotal for endothelial cell migration by mediating VEGF expression in cancer cells (English)

1 reference

11 September 2017

0 references

1 reference

4

Yong Song Gho

1 reference

11 September 2017

Seong-Moon Cheong

1

1 reference

11 September 2017

Hyemin Choi

series ordinal

2

1 reference

11 September 2017

Bok Sil Hong

series ordinal

3

1 reference

11 September 2017

Jin-Kwan Han

series ordinal

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

14 January 2012

1 reference

Experimental Cell Research

11 September 2017

1 reference

11 September 2017

318

1 reference

11 September 2017

5

1 reference

11 September 2017

550-557

1 reference

Vascular endothelial growth factor is a secreted angiogenic mitogen

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Signaling by members of the TGF-beta family in vascular morphogenesis and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor‐β induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen‐activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Down-Regulation of DOC-2 in Colorectal Cancer Points to Its Role as a Tumor Suppressor in This Malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Hematopoietic gene expression profile in zebrafish kidney marrow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Xenopus Dab2 is required for embryonic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Morphogenesis of human endothelial cells is inhibited by DAB2 via Src

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Hypoxia--a key regulatory factor in tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Angiogenesis: an organizing principle for drug discovery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

10.1016/J.YEXCR.2012.01.013

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference